The Massachusetts House passed a bill which aims to curb the use of step therapy by health insurers. Drugs that are designated with a “step therapy” condition of reimbursement are only paid for by ...

For years, I’ve watched the barriers my patients face in accessing the treatments I prescribe continue to grow. That is part of the reason I and many other health care professionals and patients ...

After President Donald Trump announced last week that the federal government will begin negotiating with drug manufacturers for lower prices on medicines paid for by Medicare Part B, discussion has ...

Depression is a chronic and progressive condition that, when not treated adequately, can lead to severe morbidity and mortality in patients and increased costs for health plans. Despite the ...

When he was diagnosed with two autoimmune diseases, Joel Hechler knew he’d be in for a battle. He didn’t realize maybe his toughest one would be with his insurance company. “I think they put the ...

An opinion forum on recent news and major policy issues. Have a story suggestion? Let us know. For the third time in the past four years, the California Legislature considered a bill that would limit ...

For people with lupus, their relationship with their healthcare team is one of the most important aspects of managing their life with lupus. Step therapy imposes on that relationship in pursuit of ...

As science makes once-unthinkable treatments available, patients are increasingly facing a harsh reality: Insurance companies are forcing them to try older, less expensive therapies for months before ...

The authors, both members of the Digestive Health Physicians Association, write about efforts in their home state and at the federal level to reform payer restrictions. As physicians, the health of ...

For roughly half my life, I have suffered from debilitating joint pain and inflammation that left me drained, fatigued, and, eventually, struggling to walk. At first, no one knew what was wrong with ...